Edition:
United Kingdom

Celcuity Inc (CELC.OQ)

CELC.OQ on NASDAQ Stock Exchange Capital Market

17.41USD
20 Apr 2018
Change (% chg)

$0.46 (+2.71%)
Prev Close
$16.95
Open
$16.79
Day's High
$17.55
Day's Low
$16.79
Volume
3,311
Avg. Vol
8,177
52-wk High
$22.13
52-wk Low
$11.10

Chart for

About

Celcuity, Inc. is a cellular analysis company. The Company is focused on discovering new cancer sub-types and commercializing diagnostic tests designed to significantly improve the clinical outcomes of cancer patients treated with targeted therapies. The Company’s proprietary CELx diagnostic platform uses a patient’s living... (more)

Overall

Beta: --
Market Cap(Mil.): $126.97
Shares Outstanding(Mil.): 9.72
Dividend: --
Yield (%): --

Financials

  CELC.OQ Industry Sector
P/E (TTM): -- 84.02 32.74
EPS (TTM): -0.48 -- --
ROI: -- 1.58 14.38
ROE: -- 2.41 16.07

BRIEF-Celcuity Reports Q4 Adjusted Non-Gaap Loss Per Share $0.14

* CELCUITY REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS

15 Mar 2018

BRIEF-Celcuity reports Q3 loss $0.26/shr

* Celcuity reports third quarter fiscal 2017 financial results

13 Nov 2017

Earnings vs. Estimates